Sinocelltech Group Limited (SHA:688520)
27.80
-1.04 (-3.61%)
Nov 17, 2026, 3:00 PM CST
Sinocelltech Group Revenue
Sinocelltech Group had revenue of 232.42M CNY in the quarter ending September 30, 2026, a decrease of -31.61%. This brings the company's total for the last twelve months to 1.14B, down -39.60% year-over-year. In the year 2025, Sinocelltech Group had annual revenue of 1.56B, down -37.91%. That makes Sinocelltech Group the 18,642nd largest company in the world by revenue and 3,412th in China.
Revenue (ttm)
1.14B
Revenue Growth
-39.60%
P/S Ratio
11.47
Revenue / Employee
504.01K
Employees
2,262
Market Cap
13.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.56B | -952.56M | -37.91% |
| Dec 31, 2024 | 2.51B | 625.36M | 33.13% |
| Dec 31, 2023 | 1.89B | 864.17M | 84.46% |
| Dec 31, 2022 | 1.02B | 888.78M | 661.33% |
| Dec 31, 2021 | 134.39M | 134.06M | 40,852.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Yili Chuanning Biotechnology | 4.06B |
| Xiamen Amoytop Biotech | 3.95B |
| Anhui Anke Biotechnology (Group) | 2.34B |
| Inner Mongolia Furui Medical Science | 1.64B |
| Jinyu Bio-technology | 1.60B |
| BrightGene Bio-Medical Technology | 1.34B |
| Acrobiosystems | 1.03B |
| GemPharmatech | 941.80M |